Model
Edge
Arca Biopharma Inc.
ABIO
Filing Type
S-3
Filing Date
4/1/2026
Updated
4/2/26, 2:05 PM
Filing
S-3
Earnings Release
Exhibits
S-3
Registration Statement for Securities Offered under a Shelf Registration
EX-5.1
OPINION OF DAVIS POLK & WARDWELL LLP RELATING TO THE BASE PROSPECTUS
EX-23.1
CONSENT OF PRICEWATERHOUSECOOPERS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-FILING FEES
FILING FEE TABLE
GRAPHIC
Graphic
GRAPHIC
Graphic